Genes and adverse childhood experiences could result in a hyperalert brain that is good at being ready for action but gives rise to insomnia in later life, according to Professor Eus Van Someren, a sleep expert at the Netherlands Institute for Neuroscience. He is investigating the link between insomnia and depression and has discovered a strong genetic correlation among the two conditions.
A cereal bar that keeps diabetes at bay is one example of how we could prevent disease by adding short molecules known as peptides into what we eat, says Dr Nora Khaldi, founder of Nuritas, which is using artificial intelligence (AI) to identify new peptides and create foods with health benefits.
Hormonal disorders can affect people's immune systems, metabolism and even bones, and unravelling the mystery around something called ultradian rhythms could help improve diagnosis and lead to better treatments, according to Professor Eystein Sverre Husebye, who works at the Department of Clinical Science at the University of Bergen (UiB) in Norway.
Entrepreneurship in Eastern Europe is on the rise, but more better communication about the funding available from the EU would help it to grow further, says Kristina Tsvetanova, the US-based co-founder and CEO of blind-accessible tablet start-up Blitab, and a 2017 winner of the EU Prize for Women Innovators.
Changing the way science is done in Europe is the first job in setting up the European open science cloud, a huge shared data repository that will enable data from all publicly-funded research to be freely accessible, according to Dr Juan Bicarregui from the Science and Technology Facilities Council, UK.
While it seems common sense that planting more trees should help remove carbon dioxide (CO2) from the atmosphere and thereby cool the planet, Europe's forest management strategies have actually not helped to fight climate change, according to Professor Sebastiaan Luyssaert, from Vrije Universiteit Amsterdam, The Netherlands.
We tend to take antibiotics for granted and not value them in a way that matches their lifesaving role, says Dr David Payne, head of the antibacterial discovery performance unit at pharmaceutical company GSK. He says that partnerships between governments and companies can help to accelerate the development of antibiotics but a new commercial model is needed to unblock the research pipeline.
High-risk, high-reward ideas in areas such as artificial intelligence (AI), blockchain and synthetic biology are typical contenders for support from the EU’s new European Innovation Council (EIC), which aims to help European innovators and entrepreneurs scale up their ideas internationally, according to Dr Hermann Hauser, serial entrepreneur, who is a founding partner of Amadeus Capital and founder of ARM in the UK.He heads up the EIC advisory board, which on 20 November published their first set of recommendations for the future direction of the EIC.
Understanding more about how solar storms interact with the outermost part of Earth's environment, known as the foreshock, could refine space weather forecasts to predict their effects at a local level and help protect vital technology, according to Dr Lucile Turc, a space physicist at the University of Helsinki, Finland.
Scientists in the Middle East are putting politics aside and using the region’s new particle accelerator, SESAME, to collaborate on experiments such as distinguishing between benign and malignant cancer tissues, and analysing historical parchments from religious texts, according to Dr Gihan Kamel, the infrared beamline scientist at the facility.She will be speaking at a session on science diplomacy at the World Science Forum in Jordan on 10 November with Carlos Moedas, the European Commissioner for Research, Science and Innovation.
Extremophile bacteria have adapted to survive inhospitable niches.
A better understanding of sleep pressure could advance therapies.
Sleep expert says that around 10 % of people are at risk of insomnia and employers should invest in therapy for those affected.